The yield of fecal occult blood testing as a screening tool for colon cancer in a primary care setting
Background/Aims: The most common cancer among men and the third most common among women in Saudi Arabia is colon cancer. This study aimed to evaluate the yield of the fecal occult blood test (FOBT) used as a screening tool for colon cancer. Settings and Design: Medical records of all patients above...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Journal of Family Medicine and Primary Care |
Subjects: | |
Online Access: | http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=8;spage=4435;epage=4439;aulast=Almoneef |
_version_ | 1798021776414867456 |
---|---|
author | Naif M Almoneef Abdullah H Alkhenizan Ahmed S Mahmoud Suad A Alsoghayer Abdulaziz A Aldheshe |
author_facet | Naif M Almoneef Abdullah H Alkhenizan Ahmed S Mahmoud Suad A Alsoghayer Abdulaziz A Aldheshe |
author_sort | Naif M Almoneef |
collection | DOAJ |
description | Background/Aims: The most common cancer among men and the third most common among women in Saudi Arabia is colon cancer. This study aimed to evaluate the yield of the fecal occult blood test (FOBT) used as a screening tool for colon cancer. Settings and Design: Medical records of all patients above the age of 50 years who had visited the Family Medicine clinic at King Faisal Specialist Hospital and Research Centre in Riyadh, Saudi Arabia and who had undergone the FOBT screening between January 2002 and March 2017 were retrospectively reviewed. Materials and Methods: We collected patients' demographic data, FOBT results, and colonoscopy pathology reports results. Statistical Analysis: Data were analyzed using the Statistical Package for Social Science Version 25 (IBM Corp., Armonk, NY, USA). Results: We included 2179 patients in this study. The mean age was 59.8 ± 8 years. As a result of the FOBT screening, 19.7% of the patients had a positive FOBT. Colon cancer accounted for 3.5% of all abnormal colonoscopy pathology reports. The Saudi age-standardized incidence rate (ASIR) in our study was 26.56 per 100,000 persons. Conclusion: FOBT is a feasible tool that can be used for colon cancer screening in primary care settings. The Saudi ASIR in our study was higher than the Saudi Cancer Registry, but it was still lower in comparison to other countries. We recommend the establishment of a national community-based colon cancer screening program. |
first_indexed | 2024-04-11T17:19:05Z |
format | Article |
id | doaj.art-6f7c571faced43e690a8b2ae979ae1d4 |
institution | Directory Open Access Journal |
issn | 2249-4863 |
language | English |
last_indexed | 2024-04-11T17:19:05Z |
publishDate | 2022-01-01 |
publisher | Wolters Kluwer Medknow Publications |
record_format | Article |
series | Journal of Family Medicine and Primary Care |
spelling | doaj.art-6f7c571faced43e690a8b2ae979ae1d42022-12-22T04:12:32ZengWolters Kluwer Medknow PublicationsJournal of Family Medicine and Primary Care2249-48632022-01-011184435443910.4103/jfmpc.jfmpc_16_22The yield of fecal occult blood testing as a screening tool for colon cancer in a primary care settingNaif M AlmoneefAbdullah H AlkhenizanAhmed S MahmoudSuad A AlsoghayerAbdulaziz A AldhesheBackground/Aims: The most common cancer among men and the third most common among women in Saudi Arabia is colon cancer. This study aimed to evaluate the yield of the fecal occult blood test (FOBT) used as a screening tool for colon cancer. Settings and Design: Medical records of all patients above the age of 50 years who had visited the Family Medicine clinic at King Faisal Specialist Hospital and Research Centre in Riyadh, Saudi Arabia and who had undergone the FOBT screening between January 2002 and March 2017 were retrospectively reviewed. Materials and Methods: We collected patients' demographic data, FOBT results, and colonoscopy pathology reports results. Statistical Analysis: Data were analyzed using the Statistical Package for Social Science Version 25 (IBM Corp., Armonk, NY, USA). Results: We included 2179 patients in this study. The mean age was 59.8 ± 8 years. As a result of the FOBT screening, 19.7% of the patients had a positive FOBT. Colon cancer accounted for 3.5% of all abnormal colonoscopy pathology reports. The Saudi age-standardized incidence rate (ASIR) in our study was 26.56 per 100,000 persons. Conclusion: FOBT is a feasible tool that can be used for colon cancer screening in primary care settings. The Saudi ASIR in our study was higher than the Saudi Cancer Registry, but it was still lower in comparison to other countries. We recommend the establishment of a national community-based colon cancer screening program.http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=8;spage=4435;epage=4439;aulast=Almoneefcolon cancercolonic polypscolonoscopyfobtsaudi arabiascreening |
spellingShingle | Naif M Almoneef Abdullah H Alkhenizan Ahmed S Mahmoud Suad A Alsoghayer Abdulaziz A Aldheshe The yield of fecal occult blood testing as a screening tool for colon cancer in a primary care setting Journal of Family Medicine and Primary Care colon cancer colonic polyps colonoscopy fobt saudi arabia screening |
title | The yield of fecal occult blood testing as a screening tool for colon cancer in a primary care setting |
title_full | The yield of fecal occult blood testing as a screening tool for colon cancer in a primary care setting |
title_fullStr | The yield of fecal occult blood testing as a screening tool for colon cancer in a primary care setting |
title_full_unstemmed | The yield of fecal occult blood testing as a screening tool for colon cancer in a primary care setting |
title_short | The yield of fecal occult blood testing as a screening tool for colon cancer in a primary care setting |
title_sort | yield of fecal occult blood testing as a screening tool for colon cancer in a primary care setting |
topic | colon cancer colonic polyps colonoscopy fobt saudi arabia screening |
url | http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=8;spage=4435;epage=4439;aulast=Almoneef |
work_keys_str_mv | AT naifmalmoneef theyieldoffecaloccultbloodtestingasascreeningtoolforcoloncancerinaprimarycaresetting AT abdullahhalkhenizan theyieldoffecaloccultbloodtestingasascreeningtoolforcoloncancerinaprimarycaresetting AT ahmedsmahmoud theyieldoffecaloccultbloodtestingasascreeningtoolforcoloncancerinaprimarycaresetting AT suadaalsoghayer theyieldoffecaloccultbloodtestingasascreeningtoolforcoloncancerinaprimarycaresetting AT abdulazizaaldheshe theyieldoffecaloccultbloodtestingasascreeningtoolforcoloncancerinaprimarycaresetting AT naifmalmoneef yieldoffecaloccultbloodtestingasascreeningtoolforcoloncancerinaprimarycaresetting AT abdullahhalkhenizan yieldoffecaloccultbloodtestingasascreeningtoolforcoloncancerinaprimarycaresetting AT ahmedsmahmoud yieldoffecaloccultbloodtestingasascreeningtoolforcoloncancerinaprimarycaresetting AT suadaalsoghayer yieldoffecaloccultbloodtestingasascreeningtoolforcoloncancerinaprimarycaresetting AT abdulazizaaldheshe yieldoffecaloccultbloodtestingasascreeningtoolforcoloncancerinaprimarycaresetting |